REQUEST A DEMO
Total
USD $0.00
Search more companies

GSK ZAO (Moscow) (Russia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: GSK ZAO Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

GSK ZAO (Moscow) is an enterprise based in Russia. Its main office is in Moscow. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. The company was established on September 11, 2002. In 2023, the company reported a net sales revenue drop of 9.66%. Its’ total assets recorded a negative growth of 13.73%. The net profit margin of GSK ZAO (Moscow) increased by 4.94% in 2023.

Headquarters
Shtepkina, 25/20, III Komnata 9
Moscow; Moscow; Postal Code: 129090

Contact Details: Purchase the GSK ZAO (Moscow) report to view the information.

Website: http://геосейсконтроль.рф

Basic Information
Outstanding Shares:
Purchase the GSK ZAO (Moscow) report to view the information.
Registered Capital:
Purchase the GSK ZAO (Moscow) report to view the information.
Incorporation Date:
September 11, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
0.34%
Purchase this report to view the information.
0.25%
Purchase this report to view the information.
0.25%
Company Performance
Financial values in the chart are available after GSK ZAO (Moscow) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-9.66%
Total operating revenue
-9.66%
Operating profit (EBIT)
38.08%
Net Profit (Loss) for the Period
39.35%
Total assets
-13.73%
Total equity
-11.09%
Operating Profit Margin (ROS)
4.72%
Net Profit Margin
4.94%
Return on Equity (ROE)
5.81%
Quick Ratio
-0.31%
Cash Ratio
-0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?